Association between the plasma proteome and plasma α-tocopherol concentrations in humans

The Journal of Nutritional Biochemistry - Tập 24 - Trang 396-400 - 2013
Laura A. Da Costa1, Bibiana García-Bailo1,2, Christoph H. Borchers3, Alaa Badawi2, Ahmed El-Sohemy1
1Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada M5S 3E2
2Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada M5V 3L7
3University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, BC, Canada V8Z 7X8

Tài liệu tham khảo

Kuzyk, 2009, Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma, Mol Cell Proteomics, 8, 1860, 10.1074/mcp.M800540-MCP200 Didangelos, 2009, Proteomics of acute coronary syndromes, Curr Atheroscler Rep, 11, 188, 10.1007/s11883-009-0030-x Mayr, 2004, Vascular proteomics: linking proteomic and metabolomic changes, Proteomics, 4, 3751, 10.1002/pmic.200400947 García-Bailo, 2011, Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: Modulation of inflammation and oxidative stress, Biologics, 5, 1 Traber, 1999, Molecular mechanisms of vitamin E transport, Annu Rev Nutr, 19, 343, 10.1146/annurev.nutr.19.1.343 Thomas, 2000, Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis, Free Radic Biol Med, 28, 1795, 10.1016/S0891-5849(00)00236-7 Devaraj, 1999, α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase, Arterioscler Thromb Vasc Biol, 19, 1125, 10.1161/01.ATV.19.4.1125 Singh, 2005, Vitamin E, oxidative stress, and inflammation, Annu Rev Nutr, 25, 151, 10.1146/annurev.nutr.24.012003.132446 Gaziano, 2004, and cardiovascular disease: observational studies, Ann N Y Acad Sci, 1031, 280, 10.1196/annals.1331.028 Mayer-Davis, 2002, Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS), Diabetes Care, 25, 2172, 10.2337/diacare.25.12.2172 Bjelakovic, 2007, Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis, J Am Med Assoc, 297, 842, 10.1001/jama.297.8.842 Ainsworth, 1993, Compendium of physical activities: classification of energy costs of human physical activities, Med Sci Sports Exerc, 25, 71, 10.1249/00005768-199301000-00011 Cahill, 2009, Vitamin C deficiency in a population of young canadian adults, Am J Epidemiol, 170, 464, 10.1093/aje/kwp156 Liu, 2011, Simultaneous measurement of three tocopherols, all-trans-retinol, and eight carotenoids in human plasma by isocratic liquid chromatography, J Chromatog Sci, 49, 221, 10.1093/chrsci/49.3.221 García-Bailo, 2012, Dietary patterns and ethnicity are associated with distinct plasma proteomic groups, Am J Clin Nutr, 95, 352, 10.3945/ajcn.111.022657 Bruno, 2005, Alpha-tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status, Am J Clin Nutr, 81, 95, 10.1093/ajcn/81.1.95 Fuss, 2001, Fibrinogen: structure, function, and surface interactions, J Vasc Interv Radiol, 12, 677, 10.1016/S1051-0443(07)61437-7 Corbett, 1998, Fibronectin-fibrin cross-linking: a regulator of cell behavior, Trends Cardiovasc Med, 8, 357, 10.1016/S1050-1738(98)00028-0 Lowe, 2004, Plasma fibrinogen, Ann Clin Biochem, 41, 430, 10.1258/0004563042466884 Folsom, 2001, Hemostatic risk factors for atherothrombotic disease: an epidemiologic view, Thromb Haemost, 86, 366, 10.1055/s-0037-1616234 Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies, J Am Med Assoc, 279, 1477, 10.1001/jama.279.18.1477 Maresca, 1999, Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update, Arterioscler Thromb Vasc Biol, 19, 1368, 10.1161/01.ATV.19.6.1368 Packard, 2000, Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease, N Eng J Med, 343, 1148, 10.1056/NEJM200010193431603 Keaney, 1999, Vitamin E and vascular homeostasis: Implications for atherosclerosis, FASEB J, 13, 965, 10.1096/fasebj.13.9.965 Leichtle, 2006, Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects, J Am Coll Nutr, 25, 420, 10.1080/07315724.2006.10719555 de Oliveira Otto, 2011, Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis, J Nutr, 141, 1508, 10.3945/jn.111.138115 Schmidt, 2007, The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function, Biomaterials, 28, 371, 10.1016/j.biomaterials.2006.08.041 Maurer, 2010, Emerging roles of fibronectin in thrombosis, Thromb Res, 125, 287, 10.1016/j.thromres.2009.12.017 Villacorta, 2003, α-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-α-mediated downregulation in human smooth muscle cells, Circ Res, 92, 104, 10.1161/01.RES.0000049103.38175.1B Frazier, 1996, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J Invest Dermatol, 107, 404, 10.1111/1523-1747.ep12363389 De Cristofaro, 2002, Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects, Thromb Haemost, 87, 58, 10.1055/s-0037-1612944 Rota, 1998, Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E, Blood, 91, 508, 10.1182/blood.V91.2.508 Ginsberg, 1986, Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo, J Clin Invest, 78, 1287, 10.1172/JCI112713 Wang, 1985, Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III, J Clin Invest, 75, 384, 10.1172/JCI111711 Shachter, 2001, Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism, Curr Opin Lipidol, 12, 297, 10.1097/00041433-200106000-00009 Kawakami, 2009, Apolipoprotein CIII links dyslipidemia with atherosclerosis, J Atheroscler Thromb, 16, 6, 10.5551/jat.E607 Chan, 2008, An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?, Int J Clin Pract, 62, 799, 10.1111/j.1742-1241.2007.01678.x Olivieri, 2010, Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation, J Thromb Haemost, 8, 463, 10.1111/j.1538-7836.2009.03720.x Borel, 2009, Br J Nutr, 101, 680, 10.1017/S0007114508030754 Major, 2011, Genome-wide association study identifies common variants associated with circulating vitamin E levels, Hum Mol Genet, 20, 3876, 10.1093/hmg/ddr296 Ishioka, 1986, Amino acid sequence of human plasma α1B-glycoprotein: homology to the immunoglobulin supergene family, Proc Natl Acad Sci U S A, 83, 2363, 10.1073/pnas.83.8.2363 Tian, 2008, Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients, BMC Cancer, 8, 241, 10.1186/1471-2407-8-241 Kreunin, 2007, Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling, J Proteome Res, 6, 2631, 10.1021/pr0700807 Yoon, 2006, Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags, Int J Oncol, 29, 315 Abdul-Rahman, 2007, Expression of high-abundance proteins in sera patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods, Electrophoresis, 28, 1989, 10.1002/elps.200600629 Puchades, 2003, Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Mol Brain Res, 118, 140, 10.1016/j.molbrainres.2003.08.005 Freedman, 1996, α-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism, Circulation, 94, 2434, 10.1161/01.CIR.94.10.2434 Traber, 2008, Vitamin E revisited: do new data validate benefits for chronic disease prevention?, Curr Opin Lipidol, 19, 30, 10.1097/MOL.0b013e3282f2dab6